These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 35787197)

  • 21. Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany.
    Weisshaar E; Bentz P; Apfelbacher C; Haufe E; Heinrich L; Heratizadeh A; Abraham S; Harder I; Kleinheinz A; Wollenberg A; Schäkel K; Wiemers F; Ertner J; Augustin M; Wildberger J; Von Kiedrowski R; Worm M; Zink A; Effendy I; Asmussen A; Pawlak M; Sticherling M; Hilgers M; Handrick C; Quist S; Schwarz B; Bell M; Staubach-Renz P; Hong-Weldemann SH; Homey B; Brücher JJ; Weidinger S; Werfel T; Schmitt J;
    Acta Derm Venereol; 2023 Jan; 103():adv00854. PubMed ID: 36688701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis.
    Rams A; Baldasaro J; Bunod L; Delbecque L; Strzok S; Meunier J; ElMaraghy H; Sun L; Pierce E
    Adv Ther; 2024 Apr; 41(4):1512-1525. PubMed ID: 38363461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Adult Atopic Dermatitis Severity With Decreased Physical Activity: A Cross-sectional Study.
    Schwartzman G; Lei D; Ahmed A; Chavda R; Gabriel S; Silverberg JI
    Dermatitis; 2023; 34(3):218-223. PubMed ID: 35951359
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of Itch and Pain on Sleep Quality in Atopic Dermatitis and Psoriasis.
    Kaaz K; Szepietowski JC; Matusiak Ł
    Acta Derm Venereol; 2019 Feb; 99(2):175-180. PubMed ID: 30307027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry data.
    Birkner T; Siegels D; Heinrich L; Haufe E; Abraham S; Heratizadeh A; Harder I; Bell M; Fell I; Worm M; Handrick C; Effendy I; Asmussen A; Kleinheinz A; Homey B; Sticherling M; Hong-Weldemann SH; Augustin M; Weisshaar E; Schäkel K; Schaefer T; Schwarz B; Wiemers F; Brücher JJ; Quist S; Wollenberg A; Biedermann T; Ertner K; von Kiedrowski R; Werfel T; Weidinger S; Schmitt J;
    J Dtsch Dermatol Ges; 2023 Oct; 21(10):1157-1168. PubMed ID: 37485573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
    Capozza K; Funk M; Hering M; Lang J; Merhand S; Manion R; Orevillo K; Picozza M; Proctor A; Schwennesen T; Begolka WS; Tullos K; Talent C; Tu M; Vastrup AS; Schwartz A
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):264-273.e1. PubMed ID: 36332836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Relevance of Skin Pain in Atopic Dermatitis.
    Ständer S; Simpson EL; Guttman-Yassky E; Thyssen JP; Kabashima K; Ball SG; Rueda MJ; DeLozier AM; Silverberg JI
    J Drugs Dermatol; 2020 Oct; 19(10):921-926. PubMed ID: 33026764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients.
    Esposito M; Amicucci G; Salfi F; Pellegrini C; De Berardinis A; Chiricozzi A; Peris K; Tempesta D; Ferrara M; Fargnoli MC
    Postgrad Med; 2024 Jun; 136(5):533-540. PubMed ID: 38864389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey.
    Silverberg JI; Mohawk JA; Cirulli J; Nograles K; Punzalan JC; Kelly KM; Kim BS; Guttman-Yassky E; Lebwohl M
    Dermatitis; 2023; 34(2):135-144. PubMed ID: 36917518
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial.
    Wollenberg A; Nakahara T; Maari C; Peris K; Lio P; Augustin M; Silverberg JI; Rueda MJ; DeLozier AM; Pierce E; Yang FE; Sun L; Ball S; Tauber M; Paul C
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1543-1552. PubMed ID: 33834521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY; Chiesa Fuxench ZC
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):340-347. PubMed ID: 30025911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient and family burden in pediatric atopic dermatitis and its treatment pattern in Japan.
    Otsuka A; Wang C; Torisu-Itakura H; Matsuo T; Isaka Y; Anderson P; Piercy J; Austin J; Marwaha S; Tanaka A
    Int J Dermatol; 2024 Nov; 63(11):e322-e334. PubMed ID: 38812086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [No Abstract]   [Full Text] [Related]  

  • 34. Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Chiesa Fuxench ZC; Simpson EL; Ong PY
    J Allergy Clin Immunol Pract; 2019; 7(8):2699-2706.e7. PubMed ID: 31228619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onset of Symptom Relief Reported in Daily Diaries of Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5).
    Rosmarin D; Casillas M; Chen S; Dawson Z; Pierce E; Zhang H; Bukhalo M; Smith S
    J Cutan Med Surg; 2022; 26(3):262-266. PubMed ID: 35086348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.
    Silverberg JI; Chiesa Fuxench ZC; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):729-734.e4. PubMed ID: 30092267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Itch characteristics in atopic dermatitis: results of a web-based questionnaire.
    Dawn A; Papoiu AD; Chan YH; Rapp SR; Rassette N; Yosipovitch G
    Br J Dermatol; 2009 Mar; 160(3):642-4. PubMed ID: 19067703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of adult atopic dermatitis and unmet needs with existing therapies.
    Bacci ED; Correll JR; Pierce EJ; Atwater AR; Dawson Z; Begolka WS; Butler L
    J Dermatolog Treat; 2023 Dec; 34(1):2202288. PubMed ID: 37042571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of atopic dermatitis severity with cognitive function in adults.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Cella D
    J Am Acad Dermatol; 2020 Nov; 83(5):1349-1359. PubMed ID: 32428607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study.
    Kim BS; Sun K; Papp K; Venturanza M; Nasir A; Kuligowski ME
    J Am Acad Dermatol; 2020 Jun; 82(6):1305-1313. PubMed ID: 32057960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.